Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Search results for: “patient perspective”

  • From Access to Eligibility: What Poland’s Real-World Stage III NSCLC Data Reveal About Treatment Pathways and Health Policy

    From Access to Eligibility: What Poland’s Real-World Stage III NSCLC Data Reveal About Treatment Pathways and Health Policy

    By

    Łukasz Kuncman, MD, PhD, DSc
    Diagnostic Oncology, Evolving Standards of Care

    Dr. Łukasz Kuncman expands on findings from a multicenter Polish study analyzing referral patterns and clinical practice in patients with unresectable stage III NSCLC, emphasizing that access to the modern standard of care depends on a chain of eligibility.

  • Knowing Before We Can Act: The Value of MRD Testing From a Patient’s Perspective

    Knowing Before We Can Act: The Value of MRD Testing From a Patient’s Perspective

    By

    Jan Pezarro
    Evolving Standards of Care, Patient Advocacy & Survivorship

    While MRD testing does not eliminate the uncertainty of recurrence, Jan Pezarro explains how advanced molecular testing provides invaluable clarity for patients.

  • IASLC Spotlight: Basic and Translational Science Committee

    IASLC Spotlight: Basic and Translational Science Committee

    By

    Haleigh Behrman
    Names & News

    From the VIKTOR platform to the upcoming IASLC Hot Topics meeting, Dr. Tom John discusses the committee’s long-term goals, ongoing projects, and future directions.

  • Under Therapeutic Pressure: ELCC Session Highlights How Tumor Switching is Reshaping the Treatment Landscape

    Under Therapeutic Pressure: ELCC Session Highlights How Tumor Switching is Reshaping the Treatment Landscape

    By

    Haleigh Behrman
    Meeting News, Targeted Therapies, Tumor Biology

    Experts emphasize the need for multidisciplinary approaches, personalized therapies, and strategies to address intratumor heterogeneity.

  • Leading by Example: A Message of Resilience, Gratitude, and Hope

    Leading by Example: A Message of Resilience, Gratitude, and Hope

    By

    Haleigh Behrman
    Meeting News, Names & News, Patient Advocacy

    During a special session at TTLC 2026, Dr. Ross Camidge shared his personal journey with lung cancer, discussing its impact on both his professional and personal life.

  • Advocate Calls for Stronger Patient Partnerships in Clinical Research

    Advocate Calls for Stronger Patient Partnerships in Clinical Research

    By

    Taylor Fithian
    Evolving Standards of Care, Meeting News, Patient Advocacy

    Jane Perlmutter, a survivor of multiple cancers, encouraged investigators to involve patient advocates at every stage of research during the TTLC 2026 Patient Advocate Session.

  • Expert Commentary on the Clinical and Surgical Implications of VPI in NSCLC

    Expert Commentary on the Clinical and Surgical Implications of VPI in NSCLC

    By

    Ramón Rami-Porta, MD, PhD
    Early Stage, Staging, Surgical Oncology

    Dr. Ramón Rami-Porta offers a surgical perspective on the secondary analysis of the CALGB 140503 trial and discusses what, if any, influence the data will have on staging guidelines.

  • A Comprehensive Framework: Integrating Smoking Cessation into LCS

    A Comprehensive Framework: Integrating Smoking Cessation into LCS

    By

    Jacek Jassem, et al.
    Global Initiatives, Lung Cancer Screening, Tobacco Control & Smoking Cessation

    Experts outline how Poland aims to reduce lung cancer mortality while addressing one of the nation’s most persistent health challenges: tobacco dependence.

  • The Importance of Compassion and Clear Communication: A Patient Advocate Perspective

    The Importance of Compassion and Clear Communication: A Patient Advocate Perspective

    By

    Kate Sinclair
    Patient Advocacy & Survivorship

    Patient advocate Kate Sinclair shares why communication is one of the most important tools for improving the patient experience during their lung cancer journey.

  • Recognized Throughout the Cancer Advocacy World for His Red Toque, Angus Pratt Brought Lung Cancer to the Fore in Many Arenas

    Recognized Throughout the Cancer Advocacy World for His Red Toque, Angus Pratt Brought Lung Cancer to the Fore in Many Arenas

    By

    Erin Jungmeyer
    Names & News, Patient Advocacy

    A real-world example of the progress that has been made in lung cancer care, ILCN editorial group member and contributor Angus Pratt survived more than seven years after his lung cancer diagnosis.

View ILCN Archives

Provider Resources

Popular Articles